update chapter 1
move chapter 1 to new file
This commit is contained in:
parent
93ceba5e1b
commit
42676db662
2 changed files with 115 additions and 0 deletions
|
@ -7,6 +7,7 @@ book:
|
||||||
date: "8/2/2022"
|
date: "8/2/2022"
|
||||||
chapters:
|
chapters:
|
||||||
- index.qmd
|
- index.qmd
|
||||||
|
- chapter1.qmd
|
||||||
- chapter2.qmd
|
- chapter2.qmd
|
||||||
- chapter3.qmd
|
- chapter3.qmd
|
||||||
- references.qmd
|
- references.qmd
|
||||||
|
|
114
chapter1.qmd
Normal file
114
chapter1.qmd
Normal file
|
@ -0,0 +1,114 @@
|
||||||
|
# Introduction
|
||||||
|
|
||||||
|
The early 20th century marked the beginning of a quality movement in
|
||||||
|
hospitals and laboratories that began with physicians and healthcare
|
||||||
|
workers. In the early part of the century, many hospitals started
|
||||||
|
reorganizing their laboratories to be headed by biochemists.
|
||||||
|
Professional organizations emerged as self-regulating groups that helped
|
||||||
|
ensure the skills and knowledge of laboratory professionals would pass
|
||||||
|
the scrutiny of the hospitals that employed them [@berger1999]. An
|
||||||
|
American Medical Association survey later showed that 48% of U.S.
|
||||||
|
hospitals had clinical laboratories by 1923 [@berger1999]. Before 1960,
|
||||||
|
almost all testing in the laboratory was performed using manual methods.
|
||||||
|
In the mid-1960s, a limited amount of automated analyzers became
|
||||||
|
available, allowing for more rapid testing and running multiple tests at
|
||||||
|
the same time [@park2017]. Since these early days of automation in the
|
||||||
|
last fifty years, the clinical laboratory has rapidly expanded
|
||||||
|
automation techniques. These include pre-packaged ready-to-use reagents,
|
||||||
|
automated dispensing, incubation and measurement, automated sample
|
||||||
|
processing (e.g., total laboratory automation systems, one- and
|
||||||
|
two-dimensional bar codes, radio frequency identification tags),
|
||||||
|
multiplexing tests from a single sample (e.g., microarrays), automated
|
||||||
|
data processing (e.g., reference range, alert value comparisons, quality
|
||||||
|
control assessment), automated interpretation (e.g., auto-verification),
|
||||||
|
image analysis (e.g., automated peripheral blood smear morphology -
|
||||||
|
CellaVision, whole slide scanning in surgical pathology), and mobile or
|
||||||
|
static robots to operate analyzers [@park2017]. This rise in automation
|
||||||
|
in the clinical laboratory has also led to the need for more advanced
|
||||||
|
computer systems to go along with the advances in instrument technology.
|
||||||
|
Over the past few decades, LISs have evolved from relatively narrow,
|
||||||
|
often arcane, or home-grown systems into sophisticated systems that are
|
||||||
|
more user-friendly and support a broader range of functions and
|
||||||
|
integration with other technologies that laboratories deploy
|
||||||
|
[@henricks2015]. Modern LISs consist of complex, interrelated computer
|
||||||
|
programs and infrastructure that support laboratories' vast array of
|
||||||
|
information-processing needs. LISs have functions in all phases of
|
||||||
|
patient testing, including specimen and test order intake, specimen
|
||||||
|
processing and tracking, support of analysis and interpretation, and
|
||||||
|
report creation and distribution. In addition, LISs provide management
|
||||||
|
reports and other data that laboratories need to run their operations
|
||||||
|
and to support continuous improvement and quality initiatives
|
||||||
|
[@henricks2015].
|
||||||
|
|
||||||
|
The clinical laboratory's primary business purpose is to provide testing
|
||||||
|
results requested by physicians and other healthcare professionals. In a
|
||||||
|
broad sense, this testing is used to help solve diagnostic problems
|
||||||
|
[@verboeket-vandevenne2012]. To continue adding value to the
|
||||||
|
laboratory's business purpose, laboratory professionals can add value
|
||||||
|
beyond just running the provided tests. Laboratory professionals can add
|
||||||
|
value through both reflective and reflex testing. Automated analyzers
|
||||||
|
add most tests based on rules (algorithms) established by laboratory
|
||||||
|
professionals; this is defined as 'reflex testing.' Clinical biochemists
|
||||||
|
add the remainder of tests after considering a more comprehensive range
|
||||||
|
of information that can readily be incorporated into reflex testing
|
||||||
|
algorithms; this is defined as 'reflective testing' [@srivastava2010].
|
||||||
|
Both reflex and reflective testing became possible with the advent of
|
||||||
|
laboratory information systems (LIS) that were sufficiently flexible to
|
||||||
|
permit modification of existing test requests at various stages of the
|
||||||
|
analytical process [@srivastava2010]. This research study will focus
|
||||||
|
specifically on reflex testing, those tests added automatically by a set
|
||||||
|
of rules established in each laboratory. In most current clinical
|
||||||
|
laboratories, reflex testing is performed with a 'hard' cutoff, using a
|
||||||
|
specifically established range with no means of flexibility
|
||||||
|
[@murphy2021]. This study will examine the use of Machine learning to
|
||||||
|
develop algorithms to allow flexibility for automatic reflex testing in
|
||||||
|
clinical chemistry. The goal is to fill the gap between hard-coded
|
||||||
|
reflex testing and fully manual reflective testing using machine
|
||||||
|
learning algorithms.
|
||||||
|
|
||||||
|
## Purpose and Research Statement
|
||||||
|
|
||||||
|
Develop and test a machine learning algorithm to establish if said
|
||||||
|
algorithm can perform better then current hard coded rules to reduced
|
||||||
|
unnecessary patient testing.
|
||||||
|
|
||||||
|
## Significance
|
||||||
|
|
||||||
|
Health spending in the U.S. increased by 4.6% in 2019 to \$3.8 trillion
|
||||||
|
or \$11,582 per capita. This growth rate is in line with 2018 (4.7
|
||||||
|
percent) and slightly faster than what was observed in 2017 (4.3
|
||||||
|
percent) [@americanmedicalassociation2021]. Although laboratory costs
|
||||||
|
comprise only about 5% of the healthcare budget in the United States, it
|
||||||
|
is estimated that laboratory services drive up to 70% of all downstream
|
||||||
|
medical decisions, which encompass a substantial portion of the budget
|
||||||
|
[@ma2019]. As healthcare budgets increase, payers, including Medicare,
|
||||||
|
commercial insurers, and employers, will demand accountability and
|
||||||
|
eliminate the abuse and misuse of ineffective testing strategies
|
||||||
|
[@hernandez2003]. Increasingly, payers demand to know the value of the
|
||||||
|
tests, with value equaling quality per unit of cost. Payers want
|
||||||
|
laboratories to prove that tests are cost-effective; as reimbursement
|
||||||
|
rates decline for many standard laboratory tests, the incentives for
|
||||||
|
automated reflex testing rise for many clinical laboratories
|
||||||
|
[@hernandez2003]. Unnecessary laboratory tests are a significant source
|
||||||
|
of waste in the United States healthcare system. Prior studies suggest
|
||||||
|
that 20% of labs performed are unnecessary, wasting 200 billion dollars
|
||||||
|
annually [@li2022].
|
||||||
|
|
||||||
|
A typical example of reflex testing is thyrotropin (TSH), relaxing to
|
||||||
|
free thyroxine (Free T4 or FT4). TSH measurement is a sensitive
|
||||||
|
screening test for thyroid dysfunction. Guidelines from the American
|
||||||
|
Thyroid Association, the American Association of Clinical
|
||||||
|
Endocrinologists, and the National Academy of Clinical Biochemistry have
|
||||||
|
endorsed TSH measurement as the best first-line strategy for detecting
|
||||||
|
thyroid dysfunction in most clinical settings [@plebani2020].
|
||||||
|
Traditionally the cutoff for reflex testing was simply the reference
|
||||||
|
range for a patient's sex and race. However, recent studies have
|
||||||
|
suggested that widening these ranges reduces reflex testing by up to 34%
|
||||||
|
[@plebani2020]. In an additional study, the authors concluded that the
|
||||||
|
TSH reference range leading to reflex Free T4 testing could likely be
|
||||||
|
widened to decrease the number of unnecessary Free T4 measurements
|
||||||
|
performed. This reduction would reduce overall costs to the medical
|
||||||
|
system without likely causing negative consequences of missing the
|
||||||
|
detection of people with thyroid hormone abnormalities
|
||||||
|
[@woodmansee2018]. Even with the potential reduction in testing, the
|
||||||
|
hard-coded reflex rule still exists.
|
Loading…
Reference in a new issue